Tell us a bit about who you are and the people you reach
Angiocrine Bioscience is a new biotech company that has developed a cellular platform for amplifying stem and progenitor cell. The expansion capacity is on an unprecedented scale when compared to any other technology. This process can meet the needs of a broad range of therapeutic , diagnostic and research applications. We have trademarked the name VeraVec for our cells.
What industry do you think your business is most related to?